Nile Therapeutics (NLTX) Misses Q3 EPS by 3c
Tweet Send to a Friend
Nile Therapeutics, Inc. (NASDAQ: NLTX) reports a Q3 loss of $0.08, 3 cents ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
